Literature DB >> 19718060

IL-21 is critical for GVHD in a mouse model.

A Meguro1, K Ozaki, I Oh, K Hatanaka, H Matsu, R Tatara, K Sato, W J Leonard, K Ozawa.   

Abstract

Immunological effects of IL-21 on T, B and natural killer (NK) cells have been reported, but the role of IL-21 in GVHD remains obscure. Here, we demonstrate that morbidity and mortality of GVHD was significantly reduced after BMT with splenocytes from IL-21R(-/-) mice compared with those from wild type mice. To further confirm our observation, we generated a decoy receptor for IL-21. GVHD was again less severe in mice receiving BM cells transduced with the IL-21 decoy receptor than control mice These results suggest that IL-21 critically regulates GVHD, and that blockade of the IL-21 signal may represent a novel strategy for the prophylaxis for GVHD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19718060      PMCID: PMC3403836          DOI: 10.1038/bmt.2009.223

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  26 in total

Review 1.  Cytokine and cytokine receptor pleiotropy and redundancy.

Authors:  Katsutoshi Ozaki; Warren J Leonard
Journal:  J Biol Chem       Date:  2002-06-18       Impact factor: 5.157

Review 2.  Cytokines and immunodeficiency diseases.

Authors:  W J Leonard
Journal:  Nat Rev Immunol       Date:  2001-12       Impact factor: 53.106

3.  Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect.

Authors:  C Schmaltz; O Alpdogan; K J Horndasch; S J Muriglan; B J Kappel; T Teshima; J L Ferrara; S J Burakoff; M R van den Brink
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

4.  Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain.

Authors:  K Ozaki; K Kikly; D Michalovich; P R Young; W J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

5.  Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6.

Authors:  Katsutoshi Ozaki; Rosanne Spolski; Rachel Ettinger; Hyoung-Pyo Kim; Gang Wang; Chen-Feng Qi; Patrick Hwu; Daniel J Shaffer; Shreeram Akilesh; Derry C Roopenian; Herbert C Morse; Peter E Lipsky; Warren J Leonard
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

6.  IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response.

Authors:  Mari Strengell; Timo Sareneva; Don Foster; Ilkka Julkunen; Sampsa Matikainen
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

7.  A critical role for IL-21 in regulating immunoglobulin production.

Authors:  Katsutoshi Ozaki; Rosanne Spolski; Carl G Feng; Chen-Feng Qi; Jun Cheng; Alan Sher; Herbert C Morse; Chengyu Liu; Pamela L Schwartzberg; Warren J Leonard
Journal:  Science       Date:  2002-11-22       Impact factor: 47.728

8.  Interleukin-21 inhibits dendritic cell activation and maturation.

Authors:  Katja Brandt; Silvia Bulfone-Paus; Donald C Foster; René Rückert
Journal:  Blood       Date:  2003-07-31       Impact factor: 22.113

9.  Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells.

Authors:  Andrea L Wurster; Vikki L Rodgers; Abhay R Satoskar; Matthew J Whitters; Deborah A Young; Mary Collins; Michael J Grusby
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

10.  Interleukin-21 is required for the development of type 1 diabetes in NOD mice.

Authors:  Andrew P R Sutherland; Tom Van Belle; Andrea L Wurster; Akira Suto; Monia Michaud; Dorothy Zhang; Michael J Grusby; Matthias von Herrath
Journal:  Diabetes       Date:  2009-02-10       Impact factor: 9.461

View more
  17 in total

1.  Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes.

Authors:  Keli L Hippen; Christoph Bucher; Dawn K Schirm; Amanda M Bearl; Ty Brender; Kathy A Mink; Kimberly S Waggie; Regis Peffault de Latour; Anne Janin; Julie M Curtsinger; Stacey R Dillon; Jeffrey S Miller; Gerard Socie; Bruce R Blazar
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

2.  Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL.

Authors:  Alan M Hanash; Lucy W Kappel; Nury L Yim; Rebecca A Nejat; Gabrielle L Goldberg; Odette M Smith; Uttam K Rao; Lindsay Dykstra; Il-Kang Na; Amanda M Holland; Jarrod A Dudakov; Chen Liu; George F Murphy; Warren J Leonard; Glenn Heller; Marcel R M van den Brink
Journal:  Blood       Date:  2011-05-19       Impact factor: 22.113

3.  Altered effector CD4+ T cell function in IL-21R-/- CD4+ T cell-mediated graft-versus-host disease.

Authors:  Iekuni Oh; Katsutoshi Ozaki; Akiko Meguro; Keiko Hatanaka; Masanori Kadowaki; Haruko Matsu; Raine Tatara; Kazuya Sato; Yoichiro Iwakura; Susumu Nakae; Katsuko Sudo; Takanori Teshima; Warren J Leonard; Keiya Ozawa
Journal:  J Immunol       Date:  2010-06-23       Impact factor: 5.422

4.  The Inflammatory Cytokine IL-21 is Expressed by Splenic Neutrophils in Response to Transplantation of Allogeneic Cells.

Authors:  John S Thompson; Debra L Hardin; Judy F Glass; Joshua Dziba; Jeffrey Campion; Stephen A Brown
Journal:  SOJ Immunol       Date:  2016

5.  Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells.

Authors:  A Meguro; K Ozaki; K Hatanaka; I Oh; K Sudo; T Ohmori; H Matsu; R Tatara; K Sato; Y Sakata; S Nakae; W J Leonard; K Ozawa
Journal:  Bone Marrow Transplant       Date:  2011-01-24       Impact factor: 5.483

6.  Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft-versus-host disease.

Authors:  Jarrod A Dudakov; Anna M Mertelsmann; Margaret H O'Connor; Robert R Jenq; Enrico Velardi; Lauren F Young; Odette M Smith; Richard L Boyd; Marcel R M van den Brink; Alan M Hanash
Journal:  Blood       Date:  2017-06-12       Impact factor: 22.113

Review 7.  The IL-17 differentiation pathway and its role in transplant outcome.

Authors:  Jonathan S Serody; Geoffrey R Hill
Journal:  Biol Blood Marrow Transplant       Date:  2012-01       Impact factor: 5.742

8.  Central Roles of OX40L-OX40 Interaction in the Induction and Progression of Human T Cell-Driven Acute Graft-versus-Host Disease.

Authors:  Trivendra Tripathi; Wenjie Yin; Yaming Xue; Sandra Zurawski; Haruyuki Fujita; Shino Hanabuchi; Yong-Jun Liu; SangKon Oh; HyeMee Joo
Journal:  Immunohorizons       Date:  2019-03

9.  IL-21 accelerates xenogeneic graft-versus-host disease correlated with increased B-cell proliferation.

Authors:  Xiaoran Wu; Yi Tan; Qiao Xing; Shengdian Wang
Journal:  Protein Cell       Date:  2013-11-10       Impact factor: 14.870

Review 10.  Translational opportunities for targeting the Th17 axis in acute graft-vs.-host disease.

Authors:  F Malard; B Gaugler; B Lamarthee; M Mohty
Journal:  Mucosal Immunol       Date:  2016-01-27       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.